SEC Form 4 · accession 0001257171-18-000003
Ainos, Inc. · AIMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen T Chen
Officer — President, CEO & Chairman · Director · 10% Owner
Period of report
Jan 31, 2018
Accepted (ET)
Feb 1, 2018 · 3:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001014763
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jan 31, 2018 | P | 2,362 | $0.27 | A | 164,578 | I | Spouse |
| COMMON STOCKF1 | Jan 31, 2018 | P | 1,250 | $0.276 | A | 165,828 | I | Spouse |
| COMMON STOCKF1 | Jan 31, 2018 | P | 850 | $0.278 | A | 166,678 | I | Spouse |
| COMMON STOCKF1 | Jan 31, 2018 | P | 5,538 | $0.28 | A | 172,216 | I | Spouse |
| COMMON STOCK | holding | — | — | — | 3,467,751 | D | ||
| COMMON STOCKF2 | holding | — | — | — | 39,473 | I | ACTS Biosciences, Inc. | |
| COMMON STOCKF3 | holding | — | — | — | 638,801 | I | STC INTERNATIONAL INC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1SPOUSE - VIRGINIA M CHEN IRA
- F2ACTS BIOSCIENCES INC - STEPHEN CHEN IS CHAIRMAN AND A BOARD MEMBER
- F3STC INTERNATIONAL INC - STEPHEN CHEN IS CHAIRMAN, BOARD MEMBER AND MAJOR SHAREHOLDER